Helping Pharma Meet International and Regulatory Standards
With over $6 billion in revenue and more than 90,000 employees, SGS operates a network of over 2,000 offices and laboratories around the world. Its life sciences division is a leading CRO that provides phase I to IV clinical trial services in Europe and the U.S., encompassing clinical project management and monitoring, biometrics, PK/PD modeling and simulation, and regulatory and medical affairs consulting.
OUT WITH THE OLD, IN WITH THE NEW
For many years, SGS was using Empirica Trace, a product developed by Phase Forward, as its safety and pharmacovigilance system. When Oracle acquired Phase Forward and decided to stop enhancing Empirica Trace, SGS needed to adopt a new solution.
SGS knew that it could choose from a variety of safety and pharmacovigilance systems available on the market. It could either move to Argus Safety, a newer solution that Oracle deemed as its flagship safety system, or it could implement a different solution from another software vendor.